Clinical Trial Update: Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing levosimendan with dobutamine in high-risk cardiovascular surgery patients; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Failure

Drugs mentioned

• Dobutamine (dobutamine)
• Levosimendan (levosimendan)

Snippet

Sponsor: Azienda Policlinico Umberto I | Conditions: Cardiovascular Diseases | Phase 4 | Status: UNKNOWN